Celanese Presents Cutting-edge Pharmaceutical Copolymer at 2015 AAPS Annual Meeting & Convention
Wed, October 21 2015
Celanese material experts will discuss the latest developments in pharmaceutical material science and how ethylene vinyl acetate (EVA) is being used in new drug delivery innovations. VitalDose® EVA controlled release excipients deliver reliable performance with customizable release properties that are compatible with many active pharmaceutical ingredients.
“The unique properties of EVA controlled release excipients allow for
customizable delivery rates that are expanding pharmaceutical
possibilities,” said
Celanese Presentation Sessions:
-
Kelsey Achenbach , strategic marketing manager, will present “Driving Pharmaceutical Innovation with EVA” onMonday, October 26, 2015 at2:05 p.m. -
Jose Reyes , strategic marketing manager, will present “EVA Foamed Excipient:Novel Way to Deliver Stem Cells, Growth Factors, and Biologics for Controlled Release Applications” in a poster presentation onTuesday, October 27, 2015 at8:30 a.m.
For more information about Celanese’s controlled release pharmaceutical EVA polymer, VitalDose® EVA, please visit www.vitaldose.com.
About Celanese
All registered trademarks are owned by
Forward-Looking Statements
This release may contain “forward-looking statements,” which include
information concerning the company’s plans, objectives, goals,
strategies, future revenues or performance, capital expenditures,
financing needs and other information that is not historical
information. When used in this release, the words “outlook,” “forecast,”
“estimates,” “expects,” “anticipates,” “projects,” “plans,” “intends,”
“believes,” and variations of such words or similar expressions are
intended to identify forward-looking statements. All forward-looking
statements are based upon current expectations and beliefs and various
assumptions. There can be no assurance that the company or any of its
customers will realize these benefits or that these expectations will
prove correct. There are a number of risks and uncertainties that could
cause actual results to differ materially from the forward-looking
statements contained in this release. Numerous factors, many of which
are beyond the company’s control, could cause actual results to differ
materially from those expressed as forward-looking statements. Other
risk factors include those that are discussed in the company’s filings
with the
View source version on businesswire.com: http://www.businesswire.com/news/home/20151021005152/en/
Investor Relations
jon.puckett@celanese.com
or
Media
Relations – Global
william.jacobsen@celanese.com
or
Media
Relations Asia (
lan.zhang@celanese.com
or
Media
Relations Europe (
j.kurth@celanese.com
Source: